Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1297

1.

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group.

Headache. 2007 Feb;47(2):170-80.

PMID:
17300356
2.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.

Cephalalgia. 2007 Jul;27(7):814-23. Epub 2007 Apr 18. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
3.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
4.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
5.

Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.

Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators.

Headache. 2005 Nov-Dec;45(10):1304-12.

PMID:
16324162
6.

Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.

Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.

Clin Ther. 2006 Jul;28(7):1002-11. Erratum in: Clin Ther. 2006 Sep;28(9):1482.

PMID:
16990078
7.

Topiramate in migraine prevention: results of a large controlled trial.

Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group.

Arch Neurol. 2004 Apr;61(4):490-5.

PMID:
15096395
8.

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.

Pediatrics. 2009 Mar;123(3):924-34. doi: 10.1542/peds.2008-0642.

PMID:
19255022
9.

Long-term migraine prevention with topiramate: open-label extension of pivotal trials.

Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.

Headache. 2006 Jul-Aug;46(7):1151-60.

PMID:
16866719
10.

Topiramate in migraine prevention: a double-blind, placebo-controlled study.

Storey JR, Calder CS, Hart DE, Potter DL.

Headache. 2001 Nov-Dec;41(10):968-75.

PMID:
11903524
11.

Topiramate for migraine prevention: a randomized controlled trial.

Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D; MIGR-002 Study Group.

JAMA. 2004 Feb 25;291(8):965-73.

PMID:
14982912
12.

Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.

Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.

Pain Med. 2008 Mar;9(2):175-85. doi: 10.1111/j.1526-4637.2007.00389.x.

PMID:
18298700
13.

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.

Mathew NT, Jaffri SF.

Headache. 2009 Nov-Dec;49(10):1466-78. doi: 10.1111/j.1526-4610.2009.01566.x.

PMID:
19912346
14.

Safety and tolerability of short-term preventive frovatriptan: a combined analysis.

MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.

Headache. 2009 Oct;49(9):1298-314. doi: 10.1111/j.1526-4610.2009.01513.x.

PMID:
19788471
15.

Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.

Lakshmi CV, Singhi P, Malhi P, Ray M.

J Child Neurol. 2007 Jul;22(7):829-35.

PMID:
17715274
16.

Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.

Cephalalgia. 2011 Jan;31(1):18-30. doi: 10.1177/0333102410372427. Epub 2010 May 17.

PMID:
20974598
17.

Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.

Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.

J Am Osteopath Assoc. 2007 Jul;107(7):251-8.

PMID:
17682112
18.

Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.

Silberstein S, Saper J, Berenson F, Somogyi M, McCague K, D'Souza J.

Neurology. 2008 Feb 12;70(7):548-55. doi: 10.1212/01.wnl.0000297551.27191.70.

PMID:
18268247
19.

Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.

Mathew NT, Kailasam J, Meadors L.

Headache. 2002 Sep;42(8):796-803.

PMID:
12390644
20.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group.

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098

Supplemental Content

Support Center